Skip to main content
Figure 2 | Cancer Cell International

Figure 2

From: Selective growth inhibition of human malignant melanoma cells by syringic acid-derived proteasome inhibitors

Figure 2

Dose-dependent anti-mitogenic effect of derivatives 2–6 on different human cancer cell lines. Human cancer cell lines (CCL233, CCL235, HTB26, HTB132, HTB 66, HTB 68) and normal fibroblast (CRL1554) were plated (27x103 cells/well) into 96 well plates and incubated at 37°C in a CO2 and non-CO2 incubators. Cells were treated with different concentrations of derivatives (0.1-2 mg/mL) for 144 h. The cell growth was measured by MTT assay.

Back to article page